125 related articles for article (PubMed ID: 24102420)
1. Improvement in precision of counting actinic keratoses.
Lee KC; Lew R; Weinstock MA
Br J Dermatol; 2014 Jan; 170(1):188-91. PubMed ID: 24102420
[TBL] [Abstract][Full Text] [Related]
2. Reliability of quantification measures of actinic keratosis.
Chen SC; Hill ND; Veledar E; Swetter SM; Weinstock MA
Br J Dermatol; 2013 Dec; 169(6):1219-22. PubMed ID: 24033340
[TBL] [Abstract][Full Text] [Related]
3. Reliability of counting actinic keratoses before and after brief consensus discussion: the VA topical tretinoin chemoprevention (VATTC) trial.
Weinstock MA; Bingham SF; Cole GW; Eilers D; Naylor MF; Kalivas J; Taylor JR; Gladstone HB; Piacquadio DJ; DiGiovanna JJ
Arch Dermatol; 2001 Aug; 137(8):1055-8. PubMed ID: 11493098
[TBL] [Abstract][Full Text] [Related]
4. The reliability of counting actinic keratosis.
Ianhez M; Fleury Junior LF; Bagatin E; Miot HA
Arch Dermatol Res; 2013 Nov; 305(9):841-4. PubMed ID: 24045957
[TBL] [Abstract][Full Text] [Related]
5. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
6. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
Beatson M; Siegel JA; Chren MM; Weinstock MA
Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
Weinstock MA; Lee KC; Chren MM; Marcolivio K;
J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
[TBL] [Abstract][Full Text] [Related]
8. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Terushkin V; Braga JC; Dusza SW; Scope A; Busam K; Marghoob AA; Gill M; Halpern AC
Dermatol Surg; 2010 Oct; 36(10):1514-20. PubMed ID: 20698872
[TBL] [Abstract][Full Text] [Related]
9. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.
Berman B; Ablon GR; Bhatia ND; Ceilley RI; Goldberg DJ; Nestor MS; Weinkle SH
J Drugs Dermatol; 2017 Mar; 16(3):260-264. PubMed ID: 28301622
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of actinic keratosis among dermatology outpatients in Austria.
Eder J; Prillinger K; Korn A; Geroldinger A; Trautinger F
Br J Dermatol; 2014 Dec; 171(6):1415-21. PubMed ID: 24864059
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.
Zhao Y; Li CY; Wen CM; Wei YB; Li RY; Wang G; Tu P
Br J Dermatol; 2016 May; 174(5):1005-10. PubMed ID: 26650251
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of actinic keratoses.
Green AC
Curr Probl Dermatol; 2015; 46():1-7. PubMed ID: 25561199
[TBL] [Abstract][Full Text] [Related]
14. The many clinico-pathologic faces of actinic keratosis: an atlas.
Massone C; Cerroni L
Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
[TBL] [Abstract][Full Text] [Related]
15. Histological intralesional heterogeneity of actinic keratoses relates to field cancerization.
Schmitz L; Stücker M; Gambichler T; Stockfleth E; Dirschka T
J Dtsch Dermatol Ges; 2018 Oct; 16(10):1211-1217. PubMed ID: 30248236
[TBL] [Abstract][Full Text] [Related]
16. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study.
Balkrishnan R; Cayce KA; Kulkarni AS; Orsagh T; Gallagher JR; Richmond D; Feldman SR
J Dermatolog Treat; 2006; 17(3):162-6. PubMed ID: 16854758
[TBL] [Abstract][Full Text] [Related]
17. Development of a treatment algorithm for actinic keratoses: a European Consensus.
Stockfleth E; Ferrandiz C; Grob JJ; Leigh I; Pehamberger H; Kerl H;
Eur J Dermatol; 2008; 18(6):651-9. PubMed ID: 18955209
[TBL] [Abstract][Full Text] [Related]
18. Chemical Peels as Field Therapy for Actinic Keratoses: A Systematic Review.
Jiang AJ; Soon SL; Rullan P; Brody HJ; Monheit GD; Lee KC
Dermatol Surg; 2021 Oct; 47(10):1343-1346. PubMed ID: 34238790
[TBL] [Abstract][Full Text] [Related]
19. Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.
Heppt MV; Steeb T; Schmitz L; Garbe C; French LE; Leiter U; Berking C
Trials; 2019 Oct; 20(1):589. PubMed ID: 31604473
[TBL] [Abstract][Full Text] [Related]
20. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
